Pediatric Diabetes Prevalence Among Medicaid Beneficiaries
Authors' conclusion
In this cross-sectional study of Medicaid-enrolled youths, the prevalence of pediatric diabetes steadily increased, underscoring an increasing public health challenge. The sharp increase in T2D highlights the urgent need for targeted prevention, screening, and management strategies to mitigate long-term health and economic consequences.
Study context
- Population
- Medicaid and Children's Health Insurance Program (CHIP) enrollees aged ≤18 years with continuous full-year enrollment, 43 US states, 2016–2021≈25–30 million youths/year
- Outcome
- Standardized annual prevalence of T1D and T2D per 1000 enrollees
- Follow-up
- 2016 to 2021
Methodological detailsnationwide, 43 states
- Nationwide
- 43 states
Main finding
As reported in the abstract
Diabetes prevalence 2016 to 2021 (per 1000 enrollees)
2.73 to 3.04
Relative increase in diabetes prevalence
11.4%
P < .001
T1D prevalence 2016 to 2021
1.99 to 2.12
6.5%
T2D prevalence 2016 to 2021
0.74 to 0.92
24.3%
Observational data: associations, not effects.
Further findings
Diabetes prevalence by urbanicity · 2016 to 2021 · values are relative increase
Relative increase in T2D prevalence by subgroup · 2016 to 2021
- Males
- 48.1%
- Residents of western US
- 51.8%
Diabetes prevalence by urbanicity · 2016 to 2021
- Rural residents had a higher prevalence of diabetes across all study years
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →